Reply to Chen et al.

FILA, Petr, Jan GOFUS, Petr NĚMEC and Jan VOJACEK. Reply to Chen et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. CARY: OXFORD UNIV PRESS INC, 2022, vol. 62, No 4, p. "ezac260", 1 pp. ISSN 1010-7940. Available from: https://dx.doi.org/10.1093/ejcts/ezac260.

Basic information

• Original name: Reply to Chen et al.
• Authors: FILA, Petr (203 Czech Republic, guarantor, belonging to the institution), Jan GOFUS (203 Czech Republic), Petr NĚMEC (203 Czech Republic, belonging to the institution) and Jan VOJACEK (203 Czech Republic).
• Edition: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, CARY, OXFORD UNIV PRESS INC, 2022, 1010-7940.

Other information

• Original language: English
• Type of outcome: Article in a journal
• Field of Study: 30201 Cardiac and Cardiovascular systems
• Country of publisher: United States of America
• Confidentiality degree: is not subject to a state or trade secret
• WWW: URL
• Impact factor: Impact factor: 3.400
• RIV identification code: RIV/00216224:14110/22:00128254
• Organization unit: Faculty of Medicine
• Doi: http://dx.doi.org/10.1093/ejcts/ezac260
• UT WoS: 000791440700001
• Keywords in English: Ross operation; Pulmonary conduit; Reoperation; Reintervention
• Tags: 14110911, rivok
• Tags: International impact, Reviewed

Abstract

We read the letter to the editor written by Chen et al. regarding our published study with great interest. We agree that the reintervention rate on both valves is of utmost importance. Therefore, we described the need for reintervention separately as follows: 9 patients (3.1%) in the Ross group had to undergo a reoperation due to autograft failure and 4 patients (1.4%) underwent a reoperation of the homograft. On the other hand, 16 patients (5.5%) underwent reoperation in the mechanical aortic valve replacement (mAVR) group. We conclude that there is no significant difference in the risk of reoperation between the Ross operation (RO) and mAVR (P = 0.54) in the mid-term postoperatively. However, only a limited number of patients in our study with a follow-up >10 years after the RO. Therefore, our ability to objectively analyse this long-term complication was limited.